Hostname: page-component-7c8c6479df-r7xzm Total loading time: 0 Render date: 2024-03-27T20:29:36.278Z Has data issue: false hasContentIssue false

Poor zinc status is associated with increased risk of insulin resistance in Spanish children

Published online by Cambridge University Press:  22 July 2011

R. M. Ortega*
Affiliation:
Departamento de Nutrición, Facultad de Farmacia, Universidad Complutense de Madrid, 28040Madrid, Spain UCM Research Group: 920030, Universidad Complutense de Madrid, 28040Madrid, Spain
E. Rodríguez-Rodríguez
Affiliation:
UCM Research Group: 920030, Universidad Complutense de Madrid, 28040Madrid, Spain Sección Departamental de Química Analítica, Facultad de Farmacia, Universidad Complutense de Madrid, 28040Madrid, Spain
A. Aparicio
Affiliation:
Departamento de Nutrición, Facultad de Farmacia, Universidad Complutense de Madrid, 28040Madrid, Spain UCM Research Group: 920030, Universidad Complutense de Madrid, 28040Madrid, Spain
A. I. Jiménez
Affiliation:
UCM Research Group: 920030, Universidad Complutense de Madrid, 28040Madrid, Spain Hospital Infantil Universitario Niño Jesús, Avenida Menéndez Pelayo 65, 28009Madrid, Spain
A. M. López-Sobaler
Affiliation:
Departamento de Nutrición, Facultad de Farmacia, Universidad Complutense de Madrid, 28040Madrid, Spain UCM Research Group: 920030, Universidad Complutense de Madrid, 28040Madrid, Spain
L. G. González-Rodríguez
Affiliation:
Departamento de Nutrición, Facultad de Farmacia, Universidad Complutense de Madrid, 28040Madrid, Spain UCM Research Group: 920030, Universidad Complutense de Madrid, 28040Madrid, Spain
P. Andrés
Affiliation:
UCM Research Group: 920030, Universidad Complutense de Madrid, 28040Madrid, Spain Sección Departamental de Química Analítica, Facultad de Farmacia, Universidad Complutense de Madrid, 28040Madrid, Spain
*
*Corresponding author: Professor R. M. Ortega, fax +34 91 394 18 10, email rortega@farm.ucm.es
Rights & Permissions [Opens in a new window]

Abstract

Zn plays a key role in the synthesis and action of insulin. The aim of the present work was to determine whether a poorer Zn status was associated with insulin resistance in a group of 357 Spanish schoolchildren. Zn intake was determined by using a 3 d food record (i.e. Sunday to Tuesday). The body weight, height and waist and hip circumferences of all subjects were recorded and fasting plasma glucose, insulin and Zn concentrations were determined. Insulin resistance was determined using the homoeostasis model assessment (HOMA) marker. Children (11·5 %) with Zn deficiency (serum Zn concentration < 10·7 μmol/l) had higher HOMA values than those with a more satisfactory Zn status (1·73 (sd 0·93)) compared with 1·38 (sd 0·90; P < 0·05). An inverse correlation was found between the HOMA value and the serum Zn concentration (r − 0·149, P < 0·05). The risk of having a greater insulin resistance value (HOMA greater than the 75th percentile) increased with age (OR 1·438; 95 % CI 1·021, 2·027) and BMI (OR 1·448; 95 % CI 1·294, 1·619) and decreased as Zn serum levels increased (OR 0·908; 95 % CI 0·835, 0·987; P < 0·001). Moreover, an inverse relationship was observed between HOMA values and Zn dietary density (r − 0·122), and the Zn intakes of male children with a HOMA value of >3·16 made a significantly smaller contribution to the coverage of those recommended (59·7 (sd 14·7) %) than observed in children with lower HOMA values (73·6 (sd 18·2) %; P < 0·05). Taking into account that Zn intake was below than that recommended in 89·4 % of the children, it would appear that increasing the intake of Zn could improve the health and nutritional status of these children, and thus contribute to diminish problems of insulin resistance.

Type
Full Papers
Copyright
Copyright © The Authors 2011

Zn, an essential trace element and a component of many enzymes, is involved in the synthesis, storage and release of insulin(Reference Gómez-García, Hernández-Salazar and González-Ortiz1Reference Jansen, Karges and Rink3). Specially, Zn plays a major role in the stabilisation of insulin hexamers and the pancreatic storage of the hormone(Reference Wiernsperger4) and is an efficient antioxidant(Reference Prasad5), while oxidative stress is considered to be a main component in the initiation and progression of insulin resistance (IR) and diabetes(Reference Kaneto, Katakami and Matsuhisa6).

Furthermore, Zn may have an indirect insulin-like effect, since genetic studies have identified the islet-restricted Zn transporter ZnT8 as a likely player in the control of insulin secretion(Reference Wiernsperger and Rapin7, Reference Rutter8). When the serum Zn concentration falls, there is a concomitant reduction in insulin secretion and peripheral insulin sensitivity(Reference Gómez-García, Hernández-Salazar and González-Ortiz1Reference Jansen, Karges and Rink3) that may increase the risk of glucose intolerance, diabetes mellitus and IR(Reference Hashemipour, Kelishadi and Shapouri2, Reference Jansen, Karges and Rink3, Reference Rutter8, Reference Sun, van Dam and Willet9).

IR is an important public health problem in children and adolescents(Reference Artz and Freemark10, Reference Lee11). It can contribute to the onset of CVD and type 2 diabetes mellitus(Reference Hashemipour, Kelishadi and Shapouri2, Reference Sun, van Dam and Willet9); anything that could prevent IR would therefore be of great public health interest. Correcting situations of Zn deficiency can reduce the risk for type 2 diabetes(Reference Sun, van Dam and Willet9) and some authors report IR or insulin sensitivity to be improved by Zn supplements(Reference Hashemipour, Kelishadi and Shapouri2, Reference Jansen, Karges and Rink3, Reference Marreiro, Geloneze and Tambascia12, Reference Kelishadi, Hashemipour and Adeli13).

Specifically, insulin sensitivity was improved in non-diabetic obese women after a Zn supplementation for 4 weeks, while no changes were observed in the placebo group(Reference Marreiro, Geloneze and Tambascia12). Kelishadi et al. (Reference Kelishadi, Hashemipour and Adeli13) evaluated the effects of zinc sulphate v. placebo on markers of IR, oxidative stress and inflammation in a sample of obese prepubescent children. This randomised, placebo-controlled, crossover trial was conducted among sixty obese children who were randomly assigned to two groups: one received 20 mg elemental Zn and the other received a placebo on a regular daily basis for 8 weeks. After a 4-week washout period, the groups were crossed over. There was no significant carryover effect, and a significant decrease was documented for apoB:apoA-I ratio, oxidised LDL, leptin and malondialdehyde, and total and LDL-cholesterol after receiving Zn supplement, while there were no significant changes after receiving a placebo. Moreover, high-sensitivity C-reactive protein decreased and markers of IR improved significantly after receiving the supplement, while they increased or impaired after receiving the placebo. Also, the mean weight, BMI and BMI Z-score decreased significantly in the supplemented group, whereas these values increased after receiving the placebo. These results are particularly important in view of the adverse consequences of both childhood obesity and early changes in markers of oxidative stress and inflammation. The authors suggest the need for studies examining the clinical usefulness of Zn supplementation in childhood obesity.

Very few studies have examined the potential effects of micronutrients on IR, particularly with respect to the paediatric age group(Reference Hashemipour, Kelishadi and Shapouri2, Reference Wiernsperger and Rapin7). Therefore, the hypothesis of the present study is that poor Zn status affects appreciable percentage of Spanish children and is associated with increased risk of IR.

Experimental methods

The present study involved six primary schools in Madrid, Spain, randomly selected from a list of all such schools in the city.

Subjects

Sample recruitment

The study subjects were 357 schoolchildren aged between 8 and 13 years. The school principals were contacted by phone to arrange an interview. Permission was requested to meet with the parents of the children in the 8- to 13-year age group. Once permission was given, the parents were explained the details of the study and all questions were answered. Signed permission was then sought to include their children in the study. All the subjects took part voluntarily.

The exclusion criteria were:

  1. (1) A lack of authorisation to take part or the non-acceptance of any of the conditions required for the study to proceed.

  2. (2) Non-attendance on days when tests or interviews were performed.

  3. (3) Having a pathology that might modify the results, that might alter food habits (and therefore nutrient intake) or that recommended non-inclusion.

This study was conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures involving human subjects/patients were approved by the Human Research Review Committee of the Pharmacy Faculty, Complutense University of Madrid. Written informed consent was obtained from all the parents of the children.

Methods

Anthropometric survey

All measurements were carried out at the schools in the morning and by following the norms set out by the World Health Organization(14).

Body weight and height were determined using a digital electronic balance (range 0·1–150 kg, precision 100 g; Seca Alpha, GmbH, Igni, France) and a Harpenden digital stadiometer (range 70–205 cm, precision 1 mm; Pfifter, Carlstadt, NJ, USA) respectively. For these measurements, subjects were barefoot and wore only underwear. Subject's BMI was calculated as weight (kg)/height2 (m2).

Overweight and obesity were defined according to BMI-specific percentiles for age and sex in the reference population. The cut-off for overweight was the 85th percentile and for obesity the 97th percentile(Reference Hernández, Castellet and Narvaiza15, Reference Rolland-Cachera, Deheeger and Bellisle16).

Waist and hip measurements were determined using a Holtain flexible metallic tape (range 0–150 cm, precision 1 mm; Holtain Limited, Crymych, Wales, UK). Measurements were carried out while the subject was standing relaxed and with the tape held snugly around the body, although not tight enough to compress the subcutaneous adipose tissue. The waist was measured midway between the inferior margin of the last rib and the crest of the ileum, in the horizontal plane. The hip circumference was measured in the horizontal plane of maximum circumference encircling the buttocks and the pubic symphysis. An assistant helped to hold the tape on the side of the subject's body opposite to the measurer. The mean of the three measurements was used for analysis. The waist:hip ratio was then calculated.

Dietary survey

A ‘weighed food record’ was kept for three consecutive days including a Sunday (from Sunday to Tuesday)(Reference Ortega, Requejo, López-Sobaler, Requejo and Ortega17). Parents were instructed to record the weights if possible – and to record the household measurements (spoonfuls, cups, etc.) if not – of all the food consumed outside school by their children. On Monday and Tuesday of the aforementioned 3 d, trained personnel visited the school canteen, recorded the foods in the menu and weighed the amounts of food served to each child plus those each left on the plate.

The energy and nutrient contents of the ingested foods were then calculated using food composition tables(Reference Ortega, López-Sobaler, Requejo, Ortega, López-Sobaler, Requejo and Andrés18). The values obtained were compared with those recommended(Reference Ortega, Requejo, Navia, Ortega, López-Sobaler, Requejo and Andrés19) to determine the adequacy of the diets. Special attention was paid to the intake of energy and Zn. Recommended intake (RI) of Zn used to estimate the percentage coverage of the RI was 10 mg/d for children under 10 years old, and 12 mg/d for girls and 15 mg/d for boys older than 10 years(Reference Ortega, Requejo, Navia, Ortega, López-Sobaler, Requejo and Andrés19). DIAL software (Alce Ingeniería, Madrid, Spain) was used to process all the data(Reference Ortega, López-Sobaler, Andrés, Ortega, López-Sobaler, Andrés, Requejo, Aparicio and Molinero20).

Theoretical energy expenditure was established by taking into account the body weight, age and physical activity of all the children, using equations proposed by the Institute of Medicine(21).

To validate the results of the dietetic study, we compared energy intake to the theoretical energy expenditure. The percentage discrepancy between the energy expenditure and the sum of the measured and declared intakes was determined using the following formula:

A negative value indicates the component involving the declared energy intake to be greater than that of the theoretical energy expenditure (probable over-reporting), while a positive value indicates it to be lower than that of the theoretical energy expenditure (probable under-reporting)(Reference Ortega, Requejo and Andrés22).

The index of nutritional quality of Zn was calculated as follows:

Physical activity

The subjects’ physical activity was examined by a questionnaire, registering the length of time spent sleeping, eating, playing sports, etc. An activity coefficient was established for each subject(Reference Ortega, Requejo, López-Sobaler, Requejo and Ortega23).

Biochemical survey

Blood samples were drawn by venipuncture between 08.00 and 09.00 hours after 12 h of fasting. The adequacy of the fasting period was checked by nurses before blood was collected.

Fasting insulin was measured by immunochemiluminometric assay(Reference El Kenz and Bergmann24) (Abbott Diagnostics, Madrid, Spain; CV = 4·8 %). Plasma glucose was determined colorimetrically using the glucose oxidase–peroxidase method (Vitros GLU Slides, Rochester, NY, USA; CV = 2·8 %)(Reference Neese, Duncan and Bayse25).

The homoeostasis model assessment (HOMA) value was used to reflect the degree of IR. This was estimated from the fasting plasma glucose and serum insulin concentrations using the following formula(Reference Albareda, Rodriguez-Espinosa and Murugo26, Reference Tripathy, Carlsson and Almgren27):

The HOMA cut-off point for the diagnosis of IR was taken as 3·16(Reference Keskin, Kurtoglu and Kendirci28).

For determination of Zn, blood was collected in trace-element-controlled Vacutainer tubes (Becton Dickinson, Le Pont de Claix, France). Serum Zn concentrations were determined by flame atomic absorption spectrometry using a Perkin-Elmer 3100 apparatus (Norwalk, CT, USA; CV = 4·1 %)(Reference Smith, Butrimovitz and Purdy29).

The cut-off level for moderate Zn deficiency was 10·7 μmol/l(Reference Pilch and Senti30, Reference Wallach and Wallach31).

Statistical analysis

Descriptive data were expressed as means and standard deviations. The Student's t test (or the Mann–Whitney test if the distribution of the results was not homogeneous) was used to compare means. The ANCOVA was used to adjust the Zn intake for under-reporting energy intake (percentage). The χ2 test was used to determine the significance of differences between proportions. Relationships between variables were quantified using multiple linear regressions controlling for potential confounders. Logistic regression analysis was used to identify risk or protection factors, expressing the OR and the 95 % CI. All calculations were performed using RSIGMA BABEL Software (Horus Hardward, Madrid, Spain). Significance was set at P < 0·05.

Results

Girls had a larger hip circumference, a higher mean serum insulin concentration, a higher mean HOMA value, a lower waist:hip ratio and a lower mean plasma glucose concentration than boys (Table 1).

Table 1 Age, blood data and anthropometric results for the studied children

(Mean values and standard deviations)

Mean values were significantly different between boys and girls: *P < 0·05, **P < 0·01, ***P < 0·001.

The Student's t test (or the Mann–Whitney test if the distribution of results was not homogeneous) was used to compare variables between boys and girls. The χ2 test was used to determine the significance of differences between proportions.

Absolute Zn intake was lower in girls, but the contribution of their intake to the coverage of the RI was greater; the RI for Zn is lower in girls 10 years or older (72 % of study subjects) (12 mg/d compared with 15 mg/d in boys)(Reference Ortega, Requejo, Navia, Ortega, López-Sobaler, Requejo and Andrés19) (Table 2). On the other hand, ANCOVA showed that Zn intake was still different between males (9·8 (sd2·1) mg/d) and females (8·54 (sd 1·8) mg/d; P < 0·001; data adjusted for percentage of under-reporting).

Table 2 Intake of energy and zinc in the studied schoolchildren

(Mean values and standard deviations)

RI, recommended intake (10 mg/d for children under 10 years old and 12 mg/d for girls and 15 mg/d for boys older than 10 years(Reference Ortega, Requejo, Navia, Ortega, López-Sobaler, Requejo and Andrés19)); INQ, index of nutritional quality (Zn density (mg/MJ)/density recommended (mg/MJ)).

Mean values were significantly different between boys and girls: ***P < 0·001.

The Student's t test (or the Mann–Whitney test if the distribution of results was not homogeneous) was used to compare variables between boys and girls. The χ2 test was used to determine the significance of differences between proportions.

Children were divided into those with a serum Zn concentration of < 10·7 and ≥ 10·7 μmol/l (Table 3). No differences were observed between these two groups in terms of the sex ratio; thus, the results for boys and girls are shown together. No differences were observed in terms of any of the anthropometric or dietetic variables measured between the concentration of < 10·7 and ≥ 10·7 μmol/l groups, although the insulin and HOMA levels were lower in the ≥ 10·7 μmol/l group (Table 3).

Table 3 Differences observed between children with a zinc deficiency and those with no such deficiency

(Mean values and standard deviations)

HOMA, homoeostatic model assessment; RI, recommended intake (10 mg/d for children under 10 years old and 12 mg/d for girls and 15 mg/d for boys older than 10 years(19)); INQ, index of nutritional quality (Zn density (mg/MJ)/density recommended (mg/MJ)).

Mean values were significantly different between boys and girls: *P < 0·05, ***P < 0·001.

The Student's t test (or the Mann–Whitney test if the distribution of results was not homogeneous) was used to compare variables between boys and girls. The χ2 test was used to determine the significance of differences between proportions.

A positive correlation was found between the HOMA value and age (r 0·237), body weight (r 0·504), height (r 0·343), BMI (r 0·463), waist circumference (r 0·510), hip circumference (r 0·478), the waist:hip ratio (r 0·180), serum insulin (r 0·984) and glucose (r 0·162), and the under-reporting intake (r 0·231). Inverse relationships were observed between the HOMA value and the serum Zn concentration (r − 0·149) and Zn dietary density (r − 0·122; P < 0·05 in all cases).

Logistic regression showed the risk of IR (i.e. a HOMA value greater than the 75th percentile) to increase with age (OR 1·438; 95 % CI 1·021, 2·027) and BMI (OR 1·448; 95 % CI 1·294, 1·619) and to diminish with increase in serum Zn concentration (OR 0·908; 95 % CI 0·835, 0·987; P < 0·001). Sex had no significant influence on this risk.

No correlation was found between Zn intake and the serum Zn concentration, although among boys with a HOMA value of >3·16, the contribution of Zn intake to the coverage of the RI (59·7 (sd 14·7) %) was significantly lower than in boys with lower HOMA values (73·6 (sd 18·2) %; P < 0·05).

Taking all the children together, when the dietary density of Zn was < p25 (0·87 mg/MJ), significantly higher HOMA values were observed than when the dietary density was higher (1·73 (sd 1·09) compared with 1·33 (sd 0·82); P < 0·01).

Discussion

The present dietetic and anthropometric results are similar to those obtained in other studies(Reference Ortega, Aparicio, Ortega, Requejo and Martínez32Reference Serra, Ribas and Aranceta34). The serum Zn concentrations and the percentage of subjects with deficient serum Zn concentrations are also similar to those previously reported(Reference Hotz, Peerson and Brown35Reference Sayeg Porto, Oliveira and Cunha37).

The percentage of children with IR in the present study (6·5 %) agrees with that reported for schoolchildren and adolescents by other authors in other countries(Reference Eisenmann, DuBose and Donnelly38Reference Manios, Moschonis and Kourlaba40). The girls had higher HOMA values than the boys (Table 1), which also agrees with that reported by other authors(Reference Manios, Moschonis and Kourlaba40, Reference Hirschler, Maccallini and Karam41), perhaps because of hormonal differences(Reference Moran, Jacobs and Steinberger42).

Children with serum Zn deficiency (concentration of < 10·7 μmol/l) had poorer glycaemia, insulin and HOMA results than the members of the ≥ 10·7 μmol/l group (Table 3). In fact, an inverse correlation was observed between serum Zn concentration and that of insulin (r − 0·1793) and the HOMA value (r − 0·149; P < 0·05 in all cases).

The risk of suffering IR (defined as a HOMA value greater than the 75th percentile) increased with age and BMI but fell with increasing serum Zn concentration (P < 0·001). Thus, Zn would appear to protect against IR, while increasing BMI and age raise the risk of IR. This influence of Zn on the HOMA value has been reported in other studies(Reference Hashemipour, Kelishadi and Shapouri2, Reference Jansen, Karges and Rink3, Reference Wiernsperger and Rapin7, Reference Sun, van Dam and Willet9).

Some authors have suggested that supplementing with Zn might help to reduce the BMI in children(Reference Lee, Lee and Bae43), and thus help reduce HOMA values. However, no such trend was observed in the present study; the children with better Zn status did not have a lower BMI than those deficient in Zn (Table 3).

As found in all previous studies(Reference Eisenmann, DuBose and Donnelly38, Reference Manios, Moschonis and Kourlaba40, Reference Chiarelli and Marcovecchio44), overweight/obese children had higher HOMA values (1·96 (sd 1·01)) than those of normal weight (1·22 (sd 0·78); P < 0·001). However, no perturbation of Zn metabolism or the very low plasma Zn concentrations that some authors associate with obesity(Reference Marreiro, Fisberg and Cozzolino45) were observed. In fact, in the present study, the overweight/obese children had serum Zn concentrations similar to those of lighter children (15·2 (sd 3·6) μmol/l compared with 15·7 (sd 3·5) μmol/l).

No correlation was found between Zn intake and serum Zn concentrations. This agrees with that reported by other authors, who indicate that homoeostatic mechanisms maintain the serum Zn concentration, with no notable change occurring when Zn intake is restricted(Reference Gibson, Hess and Hotz46, 47). However, this can be only applicable for moderate intake restrictions, which is observed in the present study and other similar studies from developed societies, since serum Zn definitely declines under severe restrictions(Reference Hashemipour, Kelishadi and Shapouri2, Reference Hotz, Peerson and Brown35, Reference Brown, Peerson and Rivera36).

Zn intake did, however, influence the HOMA value. An inverse correlation was found between the HOMA value and the dietary density of Zn (r − 0·122, P < 0·05). In addition, in children with a dietary density of Zn less than the 25th percentile, the HOMA values were significantly higher than in children with greater dietary densities. Further, boys with a HOMA value of >3·16 had Zn intakes that contributed less to the coverage of the RI than observed in those with more adequate HOMA values.

It would appear that Zn status plays a role in modulating the HOMA value and the risk of IR in children. Hashemipour et al. (Reference Hashemipour, Kelishadi and Shapouri2) earlier reported that, compared with children administered a placebo, those receiving Zn supplementation (20 mg/d) experienced significant and favourable changes in BMI, certain cardiometabolic risk factors and IR.

Some authors suggest that, given the increase in the proportion of children with IR and the metabolic syndrome, providing Zn supplementation or increasing the Zn intake through the diet might help control this emerging health problem(Reference Hashemipour, Kelishadi and Shapouri2, Reference Jansen, Karges and Rink3, Reference Marreiro, Geloneze and Tambascia12).

These studies support the results obtained in the present investigation, since we have found that children with serum Zn deficiency had poorer glycaemia, insulin and HOMA results than children with adequate serum Zn. Also, we have found that there is an inverse correlation between serum Zn concentration and HOMA value (r − 0·149) and that the risk of having HOMA greater than the 75th percentile increased with age and BMI, but fell with increasing serum Zn concentration (P < 0·001). The results of this study indicate that the risk of having greater IR reduced as serum Zn levels increased, probably due to the fact that Zn status is not optimal and can be improved.

As reported in other studies, the children's diets provided marginal Zn amounts(Reference Marreiro, Fisberg and Cozzolino45, Reference Hotz48); indeed, 89·4 % of the children in our study had Zn intakes below those recommended (Table 2).

The present study has several limitations. First, we used serum Zn as a Zn status indicator. Although its validity as a Zn status indicator can be questioned, it remains one of the best tools that we have for this purpose and is the parameter used in most studies(Reference Hashemipour, Kelishadi and Shapouri2, Reference Jansen, Karges and Rink3, Reference Marreiro, Geloneze and Tambascia12, Reference Hotz, Peerson and Brown35, Reference Brown, Peerson and Rivera36). Also, the interpretation of the association between serum Zn concentrations and the HOMA value is complex. The serum Zn concentration is sensitive to various factors that have not been determined(Reference Hashemipour, Kelishadi and Shapouri2), and further studies are needed in this issue. In any case, we consider that improving the Zn status of children is desirable from a nutritional point of view, and might help fight against IR.

Acknowledgements

This study was supported by the project FISS (PI060318) and the ‘Creation and Consolidation Program Research Group at the Complutense University of Madrid, Madrid’ (ref. GR58/08; code 4120787). None of the authors had any personal or financial conflict of interest. R. M. O., A. M. L.-S., E. R.-R. and A. A. contributed to the study design and E. R.-R., A. A., A. I. J. and L. G. G. R. performed the data collection. R. M. O., A. M. L.-S., E. R.-R., A. A. and P. A. were involved in data analysis and the interpretation of results. R. M. O., A. A., A. I. J. and P. A. contributed to the writing of the manuscript.

References

1 Gómez-García, A, Hernández-Salazar, E, González-Ortiz, M, et al. (2006) Effect of oral zinc administration on insulin sensitivity, leptin and androgens in obese males. Rev Med Chil 134, 279284.Google Scholar
2 Hashemipour, M, Kelishadi, R, Shapouri, J, et al. (2009) Effect of zinc supplementation on insulin resistance and components of the metabolic syndrome in prepubertal obese children. Hormones (Athens) 8, 279285.Google Scholar
3 Jansen, J, Karges, W & Rink, L (2009) Zinc and diabetes – clinical links and molecular mechanisms. J Nutr Biochem 20, 399417.Google Scholar
4 Wiernsperger, NF (2003) Oxidative stress as a therapeutic target in diabetes: revisiting the controversy. Diabetes Metab 29, 579585.Google Scholar
5 Prasad, AS (2008) Clinical, immunological, anti-inflammatory and antioxidant roles of zinc. Exp Gerontol 43, 370377.Google Scholar
6 Kaneto, H, Katakami, N, Matsuhisa, M, et al. (2010) Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediators Inflamm 2010, 453892.Google Scholar
7 Wiernsperger, NF & Rapin, JR (2010) Trace elements in glucometabolic disorders: an update. Diabetol Metab Syndr 2, 70.Google Scholar
8 Rutter, GA (2010) Think zinc: new roles for zinc in the control of insulin secretion. Islets 2, 4950.Google Scholar
9 Sun, Q, van Dam, RM, Willet, WC, et al. (2009) Prospective study of zinc intake and risk of type 2 diabetes in women. Diabetes Care 32, 629634.Google Scholar
10 Artz, E & Freemark, M (2004) The pathogenesis of insulin resistance in children: metabolic complications and the roles of diet, exercise and pharmacotherapy in the prevention of type 2 diabetes. Pediatr Endocrinol Rev 1, 296309.Google Scholar
11 Lee, JM (2006) Insulin resistance in children and adolescents. Rev Endocr Metab Disord 7, 141147.Google Scholar
12 Marreiro, DN, Geloneze, B, Tambascia, MA, et al. (2006) Effect of zinc supplementation on serum leptin levels and insulin resistance of obese women. Biol Trace Elem Res 12, 109118.Google Scholar
13 Kelishadi, R, Hashemipour, M, Adeli, K, et al. (2010) Effect of zinc supplementation on markers of insulin resistance, oxidative stress, and inflammation among prepubescent children with metabolic syndrome. Metab Syndr Relat Disord 8, 505510.Google Scholar
14 World Health Organization (1995) Physical Status: The Use and Interpretation of Anthropometry. Report of the WHO Expert Committee. WHO Technical Report Series no. 854. Geneva: WHO.Google Scholar
15 Hernández, M, Castellet, J, Narvaiza, JL, et al. (1988) Curvas y tablas de crecimiento (Growth Charts and Tables). Instituto de Investigación sobre crecimiento y desarrollo. Faustino Orbegozo Eizaguirre. Madrid: Editorial Garsi.Google Scholar
16 Rolland-Cachera, MF, Deheeger, M & Bellisle, F (2001) Définition actuelle et évolution de la fréquence de l'obésité chez l'enfant (Current definition and evolution of the frequency of obesity in children). Cah Nutr Diét 36, 108112.Google Scholar
17 Ortega, RM, Requejo, AM & López-Sobaler, AM (2006) Questionnaires for dietetic studies and the assessment of nutritional status. In Nutriguía. Manual of Clinical Nutrition in Primary Care, pp. 456459 [Requejo, AM and Ortega, RM, editors]. Madrid: Ed. Complutense.Google Scholar
18 Ortega, RM, López-Sobaler, AM, Requejo, AM, et al. (2010) Food composition tables. In Food Composition. A Basic Tool for Assessing Nutritional Status, pp. 1581 [Ortega, RM, López-Sobaler, AM, Requejo, AM and Andrés, P, editors]. Madrid: Ed. Complutense.Google Scholar
19 Ortega, RM, Requejo, AM, Navia, B, et al. (2010) Recommended daily intakes of energy and nutrients for the Spanish population. In Food Composition. A Basic Tool for Assessing Nutritional Status, pp. 8284 [Ortega, RM, López-Sobaler, AM, Requejo, AM and Andrés, P, editors]. Madrid: Ed. Complutense.Google Scholar
20 Ortega, RM, López-Sobaler, AM, Andrés, P, et al. DIAL software for assessing diets and food calculations, [Ortega, RM, López-Sobaler, AM, Andrés, P, Requejo, AM, Aparicio, A and Molinero, LM, editors]. Madrid: Alce Ingeniería, S.A. http://www.alceingenieria.net/nutricion.htm (accessed 1 November 2010).Google Scholar
21 Food and Nutrition Board (FNB)/Institute of Medicine (IOM) (2005) Dietary Reference Intakes: Energy, Carbohidrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids. Washington, DC: Institute of Medicine of the National Academies Press. www.nap.edu.Google Scholar
22 Ortega, RM, Requejo, AM, Andrés, P, et al. (1995) Relationship between diet composition and body mass index in a group of Spanish adolescents. Br J Nutr 74, 765773.Google Scholar
23 Ortega, RM, Requejo, AM & López-Sobaler, AM (2006) Activity questionnaire. In Nutriguía. Manual of Clinical Nutrition in Primary Care, p. 468 [Requejo, AM and Ortega, RM, editors]. Madrid: Ed. Complutense.Google Scholar
24 El Kenz, H & Bergmann, P (2004) Evaluation of immunochemiluminometric assays for the measurement of insulin and C-peptide using the ADVIA Centaur. Clin Lab 50, 171174.Google Scholar
25 Neese, JW, Duncan, P, Bayse, D, et al. (1976) Development and Evaluation of a Hexokinase/Glucose-6-phosphate Dehydrogenase Procedure for use as a National Glucose Reference Method. Atlanta: Center for Disease Control, GA. DHEW publication no. (CDC)77–8330.Google Scholar
26 Albareda, M, Rodriguez-Espinosa, J, Murugo, M, et al. (2000) Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test. Diabetologia 43, 15071511.Google Scholar
27 Tripathy, D, Carlsson, M, Almgren, P, et al. (2000) Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes 49, 975980.Google Scholar
28 Keskin, M, Kurtoglu, S, Kendirci, M, et al. (2005) Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 115, 500503.Google Scholar
29 Smith, JC Jr, Butrimovitz, GP & Purdy, WC (1979) Direct measurement of zinc in plasma by atomic absorption spectroscopy. Clin Chem 25, 14781491.Google Scholar
30 Pilch, SM & Senti, FR (1984) Assessment of the Zinc Nutritional Status of the U.S. Population based on Data Collected in the Second National Health and Nutrition Examination Survey, 1976–1980. Bethesda, MD: Life Sciences Research Office, Federation of American Societies for Experimental Biology.Google Scholar
31 Wallach, J (2007) Interpretation of diagnostic tests. In Normal Values, pp. 325 [Wallach, J, editor]. Philadelphia, PA: Wolters Kluwer. Lippincott Williams & Wilkins.Google Scholar
32 Ortega, RM & Aparicio, A (2007) Problemas nutricionales actuales. Causas y consecuencias (Current nutritional problems. Causes and Consequences). In Nutrición y Alimentación en la promoción de la salud (Food and Nutrition in Health Promotion), pp. 820 [Ortega, RM, Requejo, AM and Martínez, RM, editors]. Madrid: UIMP, UIMP Comunicación.Google Scholar
33 Rodríguez-Rodríguez, E, Navia, B, López-Sobaler, AM, et al. (2010) Associations between abdominal fat and body mass index on vitamin D status in a group of Spanish schoolchildren. Eur J Clin Nutr 64, 461467.Google Scholar
34 Serra, Ll, Ribas, L, Aranceta, J, et al. (2003) Obesidad infantil y juvenil en España. Resultados del estudio enkid (1998–2000) (Childhood and adolescent obesity in Spain. Results of the enKid study (1998–2000)). Med Clin (Barc) 121, 725732.Google Scholar
35 Hotz, C, Peerson, JM & Brown, KH (2003) Suggested lower cutoffs of serum zinc concentrations for assessing zinc status: reanalysis of the second National Health and Nutrition Examination Survey data (1976–1980). Am J Clin Nutr 78, 756764.Google Scholar
36 Brown, KH, Peerson, JM, Rivera, J, et al. (2002) Effect of supplemental zinc on the growth and serum zinc concentrations of prepubertal children: a meta-analysis of randomized controlled trials. Am J Clin Nutr 75, 10621071.Google Scholar
37 Sayeg Porto, MA, Oliveira, HP, Cunha, AJ, et al. (2000) Linear growth and zinc supplementation in children with short stature. J Pediatr Endocrinol Metab 13, 11211128.Google Scholar
38 Eisenmann, JC, DuBose, KD & Donnelly, JE (2007) Fatness, fitness, and insulin sensitivity among 7- to 9-year-old children. Obesity (Silver Spring) 15, 21352144.Google Scholar
39 Holst-Schumacher, I, Nuñez-Rivas, H, Monge-Rojas, R, et al. (2008) Insulin resistance and impaired glucose tolerance in overweight and obese Costa Rican schoolchildren. Food Nutr Bull 29, 123131.Google Scholar
40 Manios, Y, Moschonis, G, Kourlaba, G, et al. (2008) Prevalence and independent predictors of insulin resistance in children from Crete, Greece: the Children Study. Diabet Med 25, 6572.Google Scholar
41 Hirschler, V, Maccallini, G, Karam, C, et al. (2009) Are girls more insulin-resistant than boys? Clin Biochem 42, 10511056.Google Scholar
42 Moran, A, Jacobs, DR Jr, Steinberger, J, et al. (2002) Association between the insulin resistance of puberty and the insulin-like growth factor-I/growth hormone axis. J Clin Endocrinol Metab 87, 48174820.Google Scholar
43 Lee, K, Lee, J, Bae, WK, et al. (2009) Efficacy of low-calorie, partial meal replacement diet plans on weight and abdominal fat in obese subjects with metabolic syndrome: a double-blind, randomised controlled trial of two diet plans – one high in protein and one nutritionally balanced. Int J Clin Pract 63, 195201.Google Scholar
44 Chiarelli, F & Marcovecchio, ML (2008) Insulin resistance and obesity in childhood. Eur J Endocrinol 159, Suppl. 1, S67S74.Google Scholar
45 Marreiro, DN, Fisberg, M & Cozzolino, SM (2004) Zinc nutritional status and its relationships with hyperinsulinemia in obese children and adolescents. Biol Trace Elem Res 100, 137149.Google Scholar
46 Gibson, RS, Hess, SY, Hotz, C, et al. (2008) Indicators of zinc status at the population level: a review of the evidence. Br J Nutr 99, Suppl. 3, S14S23.Google Scholar
47 Food and Nutrition Board (FNB)/Institute of Medicine (IOM) (2001) Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: Institute of Medicine of the National Academies Press. www.nap.edu.Google Scholar
48 Hotz, C (2007) Dietary indicators for assessing the adequacy of population zinc intakes. Food Nutr Bull 28, Suppl. 3, S430S453.Google Scholar
Figure 0

Table 1 Age, blood data and anthropometric results for the studied children†(Mean values and standard deviations)

Figure 1

Table 2 Intake of energy and zinc in the studied schoolchildren†(Mean values and standard deviations)

Figure 2

Table 3 Differences observed between children with a zinc deficiency and those with no such deficiency†(Mean values and standard deviations)